Results 81 to 90 of about 780 (156)

Clinical characteristics, diagnosis and short‐term outcomes of COVID‐19–associated acute myocarditis in China

open access: yesESC Heart Failure, Volume 12, Issue 1, Page 338-352, February 2025.
Abstract Aims Acute myocarditis (AM) has been recognized as a rare complication of coronavirus disease 2019 (COVID‐19) infection. This study was conducted to present the clinical characteristics, disease courses and short‐term prognoses of Omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) induced AM in China, which has ...
Huihui Liu   +17 more
wiley   +1 more source

Putative HIV-1 reverse transcriptase inhibitors: design, synthesis, in vitro evaluation and in silico analysis. [PDF]

open access: yes, 2018
Masters Degree. University of KwaZulu-Natal, Durban.One of the most significant treatments for HIV-1 infection has been the combination of drugs targeting the HIV life cycle with the aim of preventing further destruction of the host immune system. This
Poonan, Preantha.
core  

Clinical Characteristics During and After COVID‐19 Infection Among Healthcare Workers During the First Wave of Omicron in Chongqing, China

open access: yesImmunity, Inflammation and Disease, Volume 13, Issue 1, January 2025.
Our study provides a comprehensive depiction of the clinical symptoms experienced by healthcare workers during and after SARS‐CoV‐2 infection in China's Omicron wave, shedding light on the intricate interplay between these symptoms and offering novel insights into the physiological impact of SARS‐CoV‐2 on human health.
Haoling Tang   +11 more
wiley   +1 more source

Review on the Implementation and Impact of the Comprehensive and Progressive Agreement for Trans-Pacific Partnership on China\u27s Pharmaceutical Economy [PDF]

open access: yes
Background: The ‘Intellectual Property Rights’ chapter of the Comprehensive and Progressive Agreement for Trans-Pacific Partnership (CPTPP) sets high international standards for intellectual property rights (IPR) protection, particularly with regard to ...
Althabhawi, Nabeel M.   +2 more
core   +2 more sources

The Role of Ursodeoxycholic Acid Administration During the COVID‐19 Pandemic: A Questionnaire Survey

open access: yesCanadian Journal of Infectious Diseases and Medical Microbiology, Volume 2025, Issue 1, 2025.
In December 2022, China classified COVID‐19 as a category B infectious disease. This ended 2 years of close epidemiological surveillance of COVID‐19. The objective of this questionnaire was to assess the infection status in the COVID‐19 pandemic since December in Henan Province, China, and the prevalence of infection in people who were taking ...
Cheng Zhou   +7 more
wiley   +1 more source

Real-world effectiveness of nirmatrelvir-ritonavir versus azvudine in hospitalized patients with COVID-19 during the omicron wave in Beijing: a multicenter retrospective cohort study

open access: yesBMC Infectious Diseases
Background and aim Two oral antivirals (Nirmatrelvir- ritonavir and Azvudine) are widely used in China practice during the Omicron wave of the pandemic.
Xiaobo Han   +20 more
doaj   +1 more source

Emerging Therapeutics in the Fight Against EV‐D68: A Review of Current Strategies

open access: yesInfluenza and Other Respiratory Viruses, Volume 18, Issue 12, December 2024.
ABSTRACT Enterovirus‐D68 (EV‐D68) was first identified in 1962 in pediatric patients with acute respiratory conditions in California, USA (US). From the 1970s to 2005, EV‐D68 was underestimated due to limited data and serotyping methods. In 2014, the United States experienced outbreaks of acute flaccid myelitis (AFM) in children EV‐D68 positive.
Nida Kalam   +1 more
wiley   +1 more source

Early Versus Delayed Usage of Paxlovid in Severe Omicron‐Infected Patients With Hypoxemia: A Prospective Multiple‐Center Cohort Study

open access: yesHealth Science Reports, Volume 7, Issue 11, November 2024.
ABSTRACT Background and Aims Early stage administration of Paxlovid has been shown to improve the prognosis of mild to moderate COVID‐19 patients with high risk. However, few evidence was validated in severe COVID‐19 patients with hypoxemia. It is also unclear whether delayed usage of Paxlovid affected prognosis in COVID‐19 patients or not.
Yu‐Ji Wang   +8 more
wiley   +1 more source

Immunophenotyping characteristics and clinical outcome of COVID-19 patients treated with azvudine during the Omicron surge. [PDF]

open access: yesFront Immunol
BackgroundLittle is known about immunophenotyping characteristics and clinical outcomes of COVID-19 patients treated with azvudine during the Omicron variant surge.MethodsThis study enrolled patients diagnosed with COVID-19 from December 2022 to February 2023.
Qiu M   +5 more
europepmc   +4 more sources

Public health equity in information asymmetry: phenomenological studies upon SARS-CoV-2 super-virus mutation [PDF]

open access: yes, 2022
In the context of SARS-CoV-2 crises, the phenomenological studies analyze the market phenomenon of People’s Republic of China (PRC) in public health. With PRC’s diplomatic behaviors around the national, international, and global public health crises, the
Pachankis, Yang
core   +1 more source

Home - About - Disclaimer - Privacy